Federal employment and cannabis — what changes when your employer is the US government

A state medical cannabis card is a state credential. It runs on state law. Where federal law applies — federal employment, security clearances, the military, commercial transport licenses, federally subsidized housing, federal firearms purchases — a state card is silent. Cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act. The state-program-versus-federal-policy gap is the most consequential blind spot for the roughly four to five million state-registered medical cannabis patients in the United States.

This hub maps the federal-employment landscape: every category of federal worker, every security-clearance tier, every transportation-industry regulation, every VA care interaction, every federal housing program. It is built to be read by people who need to make a real decision before they consume.

The framework

Federal cannabis policy operates on three overlapping layers.

Drug scheduling. The Drug Enforcement Administration classifies cannabis as Schedule I under the Controlled Substances Act of 1970. A 2024 Notice of Proposed Rulemaking from the DEA proposes rescheduling to Schedule III, which would substantially change federal taxation (282E) and research access. As of May 2026 the rule remains in proposed status; rescheduling has not occurred and Schedule I prohibitions remain in force.

Drug-free workplace. Executive Order 12564 (1986) and the Drug-Free Workplace Act of 1988 establish the framework for federal civilian agencies. Each agency adopts a drug-testing policy consistent with the federal framework. Cannabis use is disqualifying for federal employment subject to the policy, regardless of state law where the employee resides.

Security clearance. Security Executive Agent Directive 4 (SEAD-4), revised in 2021 by the Office of the Director of National Intelligence, is the governing instrument for security-clearance adjudication. Guideline H ("Drug Involvement and Substance Misuse") treats cannabis use as a basis for denial, suspension, or revocation regardless of whether the use is consistent with state law where the clearance holder resides.

These three layers compound. A state-registered medical patient who is also a federal civilian employee with a security clearance faces three independent federal disqualifications for their state-legal medical card.

Department of Defense and the uniformed services

Department of Defense Instruction 1010.04 ("Problematic Substance Use by DoD Personnel") and each service's implementing regulation prohibit cannabis use by all uniformed members of the Army, Navy, Air Force, Marine Corps, Coast Guard, and Space Force. A positive urinalysis under the random testing program triggers Article 112a (Uniform Code of Military Justice) wrongful-use proceedings. Discharge characterizations following 112a action can include general (under honorable conditions) or other-than-honorable, depending on disposition and circumstances.

A state-issued medical cannabis card is not a defense to 112a action. The UCMJ is a federal criminal statute and a state license to consume cannabis does not authorize possession or use under federal law. Service members assigned to duty stations in medical or adult-use states are subject to the federal prohibition exactly as they would be in cannabis-criminal states.

The 2022 National Defense Authorization Act included a recruiting waiver provision that allows prior cannabis use (not current use) to be considered as a potentially mitigable disqualifier during enlistment. Each service implements this differently. The waiver does not authorize current use by enlisted personnel or commissioned officers.

DoD civilian employees, contractors with access to controlled spaces, and contractors holding security clearances are subject to the civilian-side framework discussed below.

Federal civilian employment

Federal civilian agencies operate under Executive Order 12564 and the Drug-Free Workplace Act of 1988. Each agency adopts its own drug-testing policy consistent with the federal mandate. The dominant pattern is mandatory pre-employment testing, random testing for safety-sensitive positions, reasonable-suspicion testing across all positions, and post-incident testing for accidents on federal premises or in federal vehicles.

Cannabis use is disqualifying for federal civilian employment subject to a positive test. The disqualification operates regardless of state law in the employee's state of residence. The Office of Personnel Management has issued multiple memoranda (most recently 2021 and 2023) clarifying that hiring agencies should not categorically reject candidates with past cannabis use but that ongoing or current use is incompatible with federal employment.

Several federal agencies have specific additional prohibitions in their hiring frameworks: the FBI maintains a no-prior-use timeline that historically required several years of abstinence before consideration, recently relaxed; DEA and ATF maintain stringent prior-use rules consistent with their enforcement mission; the State Department's Diplomatic Security Service applies clearance-adjudication standards from initial application.

The Office of National Drug Control Policy (ONDCP) coordinates federal drug policy and publishes federal-employee guidance materials.

Security clearances and SEAD-4

Security Executive Agent Directive 4 governs federal security clearance adjudication for all national-security positions across the executive branch. The 2021 revision of SEAD-4 includes Guideline H, which addresses drug involvement and substance misuse. Cannabis use is treated under Guideline H as a basis for denial, suspension, or revocation of a clearance at any level (Confidential, Secret, Top Secret, TS/SCI).

The 2021 revision did relax some prior-use timelines. Past cannabis use that ended before the application is treated as a mitigable factor rather than an absolute bar, with the weight of mitigation depending on time elapsed, frequency, recency, and context. Current use is not mitigable. A clearance holder who acquires a state medical cannabis card and begins use cannot continue to hold the clearance lawfully under SEAD-4; the use is reportable to the clearance-granting agency and will result in adjudicative action.

Investment in or work for state-legal cannabis businesses is also addressed under SEAD-4. The 2024 ODNI guidance clarified that financial relationships with state-legal cannabis enterprises raise foreign-and-financial-influence considerations and that the guidance does not categorically disqualify but is evaluated case by case.

Clearance holders subject to SEAD-4 include intelligence-community personnel, DoD civilian and military personnel, contractors at cleared facilities, Department of Energy personnel with Q and L clearances, federal-judicial personnel with classified access, and most agency executives and special-agent positions.

Transportation industry under DOT 49 CFR Part 40

The Department of Transportation operates the most comprehensive federal drug-testing framework outside the military. DOT 49 CFR Part 40 establishes uniform testing procedures for all safety-sensitive transportation employees regulated by DOT modal administrations: FMCSA (commercial motor vehicle), FAA (aviation), FRA (rail), FTA (transit), PHMSA (pipeline), and USCG (maritime).

Cannabis is on the DOT five-drug panel. A positive marijuana test under DOT testing protocols disqualifies the worker from performing safety-sensitive duties. The prohibition extends to off-duty use in legal states. There is no medical-marijuana exemption from DOT testing. DOT issued a 2019 enforcement-policy notice reiterating that state-medical-card status is not a defense.

Affected categories:

• Commercial driver's license (CDL) holders under FMCSA Part 382. Approximately 3.5 million active CDL holders nationally.
• FAA-regulated pilots, flight attendants, mechanics, and air-traffic controllers under 14 CFR Part 120. Approximately 700,000 active certificated airmen.
• Rail workers in safety-sensitive positions under FRA Part 219. Approximately 240,000 covered employees.
• Mass-transit operators under FTA Part 655. Approximately 300,000 covered employees.
• Pipeline operators in covered functions under PHMSA Part 199.
• Mariners in safety-sensitive positions under USCG Part 16.

A positive test triggers immediate removal from safety-sensitive duty. Return to duty requires evaluation by a substance-abuse professional (SAP), completion of an SAP-prescribed treatment program, a return-to-duty test, and a follow-up testing schedule of at least six tests in the first 12 months. The DOT Clearinghouse (FMCSA's central CDL violation registry) makes the violation visible to all DOT-regulated employers nationally for five years.

The Veterans Affairs cannabis policy

Veterans Affairs medical centers and clinics are federal facilities. Under VHA Directive 1315 (last revised 2017, still operative as of 2026), VA clinicians cannot prescribe, recommend, certify, or pay for cannabis. Cannabis is not in the VA formulary and cannot be provided on VA premises.

Within those limits, VHA Directive 1315 provides several patient-protective frameworks. A veteran's participation in a state-legal medical cannabis program is not grounds for denial of any VA medical service. VA clinicians may discuss cannabis use with the patient, document state-program participation in the medical record, and continue prescribing other medications without categorical denial. The directive is explicit: state-legal cannabis use does not bar a veteran from VA care.

The compromise is real. Veterans with PTSD, chronic pain, traumatic brain injury, or spasticity from spinal-cord injury — conditions where the NASEM consensus framework supports substantial evidence for cannabinoid efficacy in adults — are common cannabis-program enrollees. Several pending federal bills (Veterans Equal Access Act, Veterans Medical Marijuana Safe Harbor Act) would authorize VA clinicians to recommend or certify under state programs. None has cleared Congress as of May 2026.

The mmjnow PTSD condition hub addresses the clinical evidence base; the VA policy framework is summarized in the federal cannabis status hub.

Federal firearms and ATF Form 4473

Federal firearms purchases at any FFL (federal firearms licensee) require completion of ATF Form 4473. Question 21.f of the current form (revised January 2023) reads:

Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance? Warning: The use or possession of marijuana remains unlawful under Federal law regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside.

A truthful affirmative answer disqualifies the purchase. A false negative answer is a federal felony under 18 USC 922(g)(3) (federal firearms law) and 18 USC 924(a)(1)(A) (false statement on Form 4473). The latter carries a statutory maximum of 10 years' imprisonment.

The disqualification operates regardless of state medical-card status. The ATF has consistently maintained that a state-issued medical card establishes "use" within the meaning of 922(g)(3). The Fifth Circuit's 2023 Daniels decision created some constitutional uncertainty about 922(g)(3) as applied to occasional marijuana users; the issue is unsettled and the form text and federal enforcement framework remain as stated.

Federally subsidized housing

Public housing authorities under the Department of Housing and Urban Development and project-based and tenant-based Section 8 landlords operate under HUD's 2014 guidance memorandum on marijuana use, which remains operative. The memo directs PHAs to deny admission to current marijuana users and authorizes (but does not require) termination of tenancy for ongoing use.

Implementation varies dramatically by housing authority. Some PHAs in adult-use states have formally adopted non-enforcement policies for state-legal cannabis use. Others enforce strictly. Tenants in federally subsidized housing should confirm the local policy before consuming on the premises.

The HUD framework does not apply to FHA-insured mortgages on owner-occupied housing or to Low-Income Housing Tax Credit (LIHTC) properties at the federal level (though state allocating agencies sometimes impose their own conditions).

States with explicit federal-employment guidance

Several mmjnow state hubs include a dedicated federal-employment section because of the concentration of federal workforce in those states. The grid below lists those hubs. Other state hubs include the federal disclaimer in their standard disclaimers; the dedicated sections below carry the deepest detail.

Implementation guidance

Federal employees, contractors, clearance holders, military service members, CDL holders, and other federally regulated workers should treat the state medical-card decision as a binary. If you fall into any of the federal categories above, a state medical card is not a workable harm-reduction tool for cannabis use — the underlying federal prohibition is not modified by state action and the personal consequences (termination, clearance revocation, license loss, criminal exposure) are larger than the medical-card benefits.

Workers facing this decision should:

1. Read your specific federal framework. Each category — DoD uniformed, federal civilian agency, clearance holder, DOT-regulated, VA patient, HUD-subsidized resident — has slightly different rules and review the directives linked in this hub directly.
2. Read your employer's specific policy. Many agencies and contractors publish detailed drug-policy guidance that goes beyond the federal floor.
3. Consult an attorney with federal-employment or security-clearance expertise before action. The mmjnow editorial team is not a law firm. The categorical guidance on this hub is not a substitute for personalized legal advice.

Where federal status may change

Three federal reforms could materially modify the landscape.

The DEA's 2024 proposed rule to reschedule cannabis to Schedule III, if finalized, would change federal taxation under IRC §280E and expand research access. Schedule III would not legalize use; it would not modify the drug-free-workplace framework; it would not change SEAD-4 by itself. But Schedule III status could prompt downstream rulemaking and policy review at OPM, DoD, DOT, VA, and HUD that softens specific implementations.

The SAFE Banking Act (now SAFER Banking) addresses state-legal cannabis businesses' access to federal banking. It does not modify drug-scheduling, drug-free-workplace, or clearance policy. Its enactment would, however, signal a congressional intent to integrate state-legal cannabis with federal economic infrastructure that could provide political momentum for downstream reforms.

The Veterans Equal Access Act would authorize VA clinicians to recommend or certify under state medical programs. It does not modify state laws; it modifies federal clinician prohibition. It is the federal reform most directly relevant to medical-cannabis patients in the federal workforce.

The mmjnow federal cannabis status hub tracks all three.

Frequently asked questions

The five most-common questions about federal cannabis policy and employment are answered at the top of this hub (visible in the FAQ schema). For the clinical evidence base for cannabis as a treatment for veteran-prevalent conditions see the PTSD, chronic pain, and traumatic brain injury hubs. For the federal status timeline see federal cannabis status 2026.